HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Infection of bloodstream — Clinical Guidelines

Overview

Bloodstream infections (BSIs) involve the invasion of the circulatory system by pathogens, leading to significant morbidity and mortality. These infections can originate from various sources, including central venous catheters, and are associated with high healthcare costs and extended hospital stays 1 7.

Diagnosis

Key Diagnostic Criteria: Positive blood cultures identifying the pathogen 3 12.

Recommended Tests: Blood cultures are essential; rapid diagnostic tests (RDTs) such as nucleic acid amplification tests (NAATs) and matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) can expedite identification 3 12.

Grading: Use of standardized criteria like those from the National Healthcare Safety Network (NHSN) for accurate surveillance 25.

Management

First-Line Treatments:

- Piperacillin/tazobactam: Considered effective for infections due to bacteria producing chromosomal AmpC beta-lactamase 2. - Carbapenems: Often used for severe infections, especially with multidrug-resistant organisms 14.

Antibiotic Duration: A 7-day course of antibiotics is noninferior to 14 days for BSIs 5.

Adjunctive Measures:

- Antiseptic Barrier Caps (ABCs): Reduce CLABSI rates when used with central venous catheters 11 13. - Taurolidine-citrate lock solution: Effective in reducing CLABSI rates in high-risk pediatric populations 16.

Special Populations

Pediatrics: Delayed adequate antimicrobial treatment correlates with increased organ dysfunction 10. PICC line management should consider repair over exchange to preserve venous access 20.

Elderly: Higher BMI is associated with increased mortality and organ failure in Gram-negative BSIs 22.

Comorbidities: Patients with hematological malignancies face higher risks with carbapenem-resistant Pseudomonas aeruginosa BSIs, influenced by factors like neutropenia and prior antifungal use 9.

Key Recommendations

Implement Antiseptic Barrier Caps to reduce central line-associated bloodstream infections (CLABSIs) 11 13 (Evidence: Strong).

Use a 7-day antibiotic course for bloodstream infections when appropriate, balancing efficacy and duration 5 (Evidence: Moderate).

Employ Rapid Diagnostic Tests (RDTs) to expedite pathogen identification and guide antimicrobial therapy 3 12 (Evidence: Moderate).

Enhance Infection Control Practices, including sterile techniques during central venous catheter placement, to minimize infection risks 1 23 (Evidence: Strong).

Monitor and Manage BMI in patients with Gram-negative BSIs to mitigate adverse outcomes 22 (Evidence: Moderate).

References

1 Rosenthal VD, Memish ZA, Shweta F, Bearman G, Lutwick LI. Preventing central line-associated bloodstream infections: A position paper of the International Society for Infectious Diseases, 2024 update. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2025. link 2 Onorato L, de Luca I, Salvati A, Monari C, Coppola N. Piperacillin/tazobactam vs. cefepime or carbapenems for the treatment of bloodstream infections due to bacteria producing chromosomal AmpC beta-lactamase: a systematic review and meta-analysis. Infection 2025. link 3 Wolk DM, Parrott JS, Babady NE, Mochon AB, Tom R, Diel C et al.. The American Society for Microbiology's evidence-based laboratory medicine practice guidelines for the diagnosis of bloodstream infections using rapid tests: a systematic review and meta-analysis. Clinical microbiology reviews 2025. link 4 Rosenberg K. Increased risk of bloodstream infections with longer PIVC dwell time. The American journal of nursing 2025. link 5 Rosenberg K. Seven-day course of antibiotics is noninferior to 14 days for bloodstream infections. The American journal of nursing 2025. link 6 Peri AM, Chatfield MD, Ling W, Furuya-Kanamori L, Harris PNA, Paterson DL. Rapid Diagnostic Tests and Antimicrobial Stewardship Programs for the Management of Bloodstream Infection: What Is Their Relative Contribution to Improving Clinical Outcomes? A Systematic Review and Network Meta-analysis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2024. link 7 Elangovan S, Lo JJ, Xie Y, Mitchell B, Graves N, Cai Y. Impact of central-line-associated bloodstream infections and catheter-related bloodstream infections: a systematic review and meta-analysis. The Journal of hospital infection 2024. link 8 Pezzani MD, Arieti F, Rajendran NB, Barana B, Cappelli E, De Rui ME et al.. Frequency of bloodstream infections caused by six key antibiotic-resistant pathogens for prioritization of research and discovery of new therapies in Europe: a systematic review. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2024. link 9 Yuan F, Li M, Wang X, Fu Y. Risk factors and mortality of carbapenem-resistant Pseudomonas aeruginosa bloodstream infection in haematology department: A 10-year retrospective study. Journal of global antimicrobial resistance 2024. link 10 Pong S, Fowler RA, Fontela P, Gilfoyle E, Hutchison JS, Jouvet P et al.. Association of delayed adequate antimicrobial treatment and organ dysfunction in pediatric bloodstream infections. Pediatric research 2024. link 11 Gillis VELM, van Es MJ, Wouters Y, Wanten GJA. Antiseptic barrier caps to prevent central line-associated bloodstream infections: A systematic review and meta-analysis. American journal of infection control 2023. link 12 Andersson Norlén E, Widerström M, Lindam A, Olsson J, Ryding U. Blood cultures with one venipuncture instead of two: a prospective clinical comparative single-center study including patients in the ICU, haematology, and infectious diseases departments. Infectious diseases (London, England) 2023. link 13 Tejada S, Leal-Dos-Santos M, Peña-López Y, Blot S, Alp E, Rello J. Antiseptic barrier caps in central line-associated bloodstream infections: A systematic review and meta-analysis. European journal of internal medicine 2022. link 14 Qu J, Feng C, Li H, Lv X. Antibiotic strategies and clinical outcomes for patients with carbapenem-resistant Gram-negative bacterial bloodstream infection. International journal of antimicrobial agents 2021. link 15 Tang W, Zhang W, Li X, Cheng J, Liu Z, Zhou Q et al.. Hematological parameters in patients with bloodstream infection: A retrospective observational study. Journal of infection in developing countries 2020. link 16 Chong CY, Ong RY, Seah VX, Tan NW, Chan MY, Soh SY et al.. Taurolidine-citrate lock solution for the prevention of central line-associated bloodstream infection in paediatric haematology-oncology and gastrointestinal failure patients with high baseline central-line associated bloodstream infection rates. Journal of paediatrics and child health 2020. link 17 McNamara JF, Harris PNA, Chatfield MD, Lorenc P, Paterson DL. Measuring patient-centred long-term outcome following a bloodstream infection: a pilot study. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2020. link 18 Diallo K, Kern WV, de With K, Luc A, Thilly N, Pulcini C. Management of bloodstream infections by infection specialists in France and Germany: a cross-sectional survey. Infection 2018. link 19 Mobley RE, Bizzarro MJ. Central line-associated bloodstream infections in the NICU: Successes and controversies in the quest for zero. Seminars in perinatology 2017. link 20 Gnannt R, Patel P, Temple M, Al Brashdi Y, Amaral J, Parra D et al.. Peripherally Inserted Central Catheters in Pediatric Patients: To Repair or Not Repair. Cardiovascular and interventional radiology 2017. link 21 Kim M, Song KH, Kim CJ, Song M, Choe PG, Park WB et al.. Electronic Alerts with Automated Consultations Promote Appropriate Antimicrobial Prescriptions. PloS one 2016. link 22 Lizza BD, Rhodes NJ, Esterly JS, Toy C, Lopez J, Scheetz MH. Impact of body mass index on clinical outcomes in patients with gram-negative bacteria bloodstream infections. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 2016. link 23 Hoskote SS, Khouli H, Lanoix R, Rose K, Aqeel A, Clark M et al.. Simulation-based training for emergency medicine residents in sterile technique during central venous catheterization: impact on performance, policy, and outcomes. Academic emergency medicine : official journal of the Society for Academic Emergency Medicine 2015. link 24 Süner A, Karaoğlan I, Mete AO, Namiduru M, Boşnak V, Baydar I. Assessment of bloodstream infections and risk factors in an intensive care unit. Turkish journal of medical sciences 2015. link 25 Gaur AH, Miller MR, Gao C, Rosenberg C, Morrell GC, Coffin SE et al.. Evaluating application of the National Healthcare Safety Network central line-associated bloodstream infection surveillance definition: a survey of pediatric intensive care and hematology/oncology units. Infection control and hospital epidemiology 2013. link 26 Daneman N, Shore K, Pinto R, Fowler R. Antibiotic treatment duration for bloodstream infections in critically ill patients: a national survey of Canadian infectious diseases and critical care specialists. International journal of antimicrobial agents 2011. link 27 Lesprit P, Merabet L, Fernandez J, Legrand P, Brun-Buisson C. Improving antibiotic use in the hospital: Focusing on positive blood cultures is an effective option. Presse medicale (Paris, France : 1983) 2011. link 28 Horii T, Tamai K, Mitsui M, Notake S, Yanagisawa H. Blood stream infections caused by Acinetobacter ursingii in an obstetrics ward. Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases 2011. link 29 Bénet T, Vanhems P. Correlation of nosocomial bloodstream infection incidences: an ecological study. The Journal of hospital infection 2009. link

Infection of bloodstream